SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-030694
Filing Date
2017-02-03
Accepted
2017-02-03 16:05:55
Documents
4
Period of Report
2017-02-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d325931d8k.htm 8-K 17227
2 EX-1.1 d325931dex11.htm EX-1.1 215426
3 EX-5.1 d325931dex51.htm EX-5.1 7877
4 GRAPHIC g325931g0203052717163.jpg GRAPHIC 2368
  Complete submission text file 0001193125-17-030694.txt   245234
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36500 | Film No.: 17572131
SIC: 2834 Pharmaceutical Preparations